Combining Serum DNA Methylation Biomarkers and Protein Tumor Markers Improved Clinical Sensitivity for Early Detection of Colorectal Cancer
Background. Colorectal cancer (CRC) is one of the leading causes of cancer deaths worldwide and in China. Early CRC screening is the best approach to reduce its incidence and mortality rates. The ColoDefense test, a multiplex qPCR assay simultaneously detecting both methylated SEPT9 and SDC2 genes,...
Saved in:
Main Authors: | Guoying Zhang, Fang He, Guodong Zhao, Zihui Huang, Xiang Li, Xia Xia, Yidi Guo, Weiping Xu, Shangmin Xiong, Yong Ma, Minxue Zheng, Wanli Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | International Journal of Genomics |
Online Access: | http://dx.doi.org/10.1155/2021/6613987 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>CYP24A1</i> DNA Methylation in Colorectal Cancer as Potential Prognostic and Predictive Markers
by: Ru-Hua Zhou, et al.
Published: (2025-01-01) -
Blood-based DNA methylation markers for lung cancer prediction
by: Marc Chadeau-Hyam, et al.
Published: (2024-07-01) -
Inflammatory Serum Biomarkers in Colorectal Cancer in Kazakhstan Population
by: L. Akhmaltdinova, et al.
Published: (2020-01-01) -
Causality-driven candidate identification for reliable DNA methylation biomarker discovery
by: Xinlu Tang, et al.
Published: (2025-01-01) -
Tumour DNA methylation markers associated with breast cancer survival: a replication study
by: Elaheh Zarean, et al.
Published: (2025-01-01)